CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 51 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 3.08 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 2,687,381 | $38,430,000 | 10.58% |
| Novo Holdings A/S | 3,224,046 | $46,104,000 | 4.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 320,229 | $4,579,000 | 1.16% |
| Orbimed Advisors | 5,379,349 | $76,925,000 | 0.98% |
| Avoro Capital Advisors LLC | 216,619 | $3,098,000 | 0.63% |
| Rock Springs Capital Management LP | 450,000 | $6,435,000 | 0.43% |
| Cormorant Asset Management, LP | 198,526 | $2,839,000 | 0.38% |
| EverPoint Asset Management, LLC | 417,849 | $5,975,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 21,292 | $304,000 | 0.05% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 9,402 | $134,000 | 0.02% |